Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

A new survey by eHealth and Retirable finds that 80% of Americans worry Medicare and Social Security won’t be available when ...

A new study found that commercial insurers pay hospitals more than twice what Medicare does, with prices varying depending on ...

An expert discusses how vitiligo patients commonly develop thyroid disease as a comorbidity and face increased skin cancer risk while highlighting the urgent need for new treatments beyond the single ...

An expert discusses how vitiligo significantly affects patients’ psychosocial health due to its visible nature, unpredictable course, slow treatment response, and particularly severe impact on younger ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

In an interview with Managed Healthcare Executive, Yosi Health CEO Hari Prasad praised insurers' new voluntary pledge to simplify prior authorization, calling it a key step toward faster care and ...

Patients using steroids, especially at high-doses, before taking immune checkpoint inhibitors for non–small cell lung cancer ...

Michael Abrams, M.A., managing partner at Numerof & Associates, warned that without clear eligibility rules, the new $50 ...

Employers must provide clear, intelligent guidance upfront instead of asking employees to navigate a complex labyrinth of ...